NCT00192361View on ClinicalTrials.gov

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 1999

Conditions

Influenza

Interventions

BIOLOGICAL

CAIV-T

Trial Locations (1)

33101

Kauppakatu Clinic, Tampere

Sponsors

Lead Sponsor

All Listed Sponsors

lead

MedImmune LLC

INDUSTRY